cel-sci.com (CVM) Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi
CEL-SCI Corporation uzoq davom etgan ishlanmalar muddatlari tufayli investorlarning shubhalari ostida faoliyat yuritmoqda. Uzoq muddatli moliyaviy leveraj koeffitsiyenti joriy barqarorlikni namoyish etmoqda, bunda 0.45 qiymati qarzlarining joriy darajasini aks ettiradi. Istiqbollar GMP ob'ektlarining sertifikatshtirilishi va Multikine muvaffaqiyatiga, shuningdek, markazlar o'rtasida tajriba vaksinalarining nuqsonsiz tashilishi bilan bog'liq.
CEL-SCI Corp. (CVM) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi tafsilotlari:
- emitentning balans qiymati statistikasi:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Barcha qarzlarning o‘z mablag‘lariga nisbati CEL-SCI Corporation|CVM - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati CEL-SCI Corp|CVM - Kompaniyaning jamlangan qarzlari|Qarzning balans qiymatiga nisbati CEL-SCI Corporation|CVM - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari CEL-SCI|Oraliq qoplash koeffitsiyenti cel-sci.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning jamlanma tahlili:CVM cel-sci.com
Ushbu koeffitsiyent kapital tuzilmasidagi uzoq muddatli majburiyatlarning ulushini belgilab, kompaniyaning moliyaviy leveraj darajasini o'lchaydi. Ushbu metrikaning oshishi kredit yukining ortishidan dalolat beradi, bu esa daromad o'sish sur'atlari bilan korrelyatsiyani talab qiladi. Uzoq muddatli qarzlarning kapitalga nisbatan dinamikasini tahlil qilish orqali investor qarz siyosatining haqiqiy trayektoriyasini aniqlashi mumkin. CEL-SCI Corporation (CVM) uchun past qiymatlar ishlab chiqarish autsorsingining samaradorligini tasdiqlaydi. Sezilarli kapital xarajatlarining yo'qligi uzoq muddatli kreditlar olishga bo'lgan ehtiyojni minimallashtiradi.
Raqobatdosh kompaniyalar
Uzoq muddatli qarzning kapitalga nisbati BeiGene Ltd.|Uzoq muddatli qarzning o'z kapitaliga nisbati Halozyme Inc. (HALO)|Revolution Medicines Corp - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati AAPG (Ascentage Pharma Group)|CGON - Uzoq muddatli qarzning o'z kapitaliga nisbati|UroGen Pharma - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Bicara Therapeutics Inc|Personalis Corp (PSNL) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Erasca Oncology - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati DCTH|YMAB: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati AURA|Uzoq muddatli qarzning o'z kapitaliga nisbati candeltx.com CADL|Accuray Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati SELLAS Life Sciences Group, Inc. SLS|ACTU - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CTOR (citiusonc.com)|HURA: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Protara Therapeutics Inc (TARA)|FATE (Fate Therapeutics Corp) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Aadi Bio (WHWK)|Uzoq muddatli qarzning kapitalga nisbati TCRX|CSBR - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati XBiotech XBIT|OS Therapies Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|RADX: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Artiva Biotherapeutics, Inc. (ARTV)|adlainortye.com (ANL) - Uzoq muddatli qarzning o'z kapitaliga nisbati|VERU - Uzoq muddatli qarzdorlikning kapitalga nisbati|TPST (Tempest Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Xilio (XLO)|Uzoq muddatli qarzning kapitalga nisbati RENB|Uzoq muddatli qarzdorlikning kapitalga nisbati muraloncology.com|Kairos Pharma - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti OKUR|CytoMed - Uzoq muddatli qarzning kapitalga nisbati|Curis, Inc. (CRIS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|apollomicsinc.com (APLM) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Tharimmune Corporation (THAR)|Uzoq muddatli qarzning o'z kapitaliga nisbati Advanced Biomed Inc.|GNPX: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Calidi Biotherapeutics (CLDI)|SBFM: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Xenetic Biosciences, Inc. XBIO|Salarius Pharma (SLRX) - Uzoq muddatli majburiyatlarning kapitalga nisbati|PPBT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti AONC (American Oncology Network)|BGNE: Uzoq muddatli qarzning kapitalga nisbati|Checkpoint Therapeutics Inc. (CKPT) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ELEV|ICAD (iCAD Corp) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati IKNA|Uzoq muddatli qarzdorlikning kapitalga nisbati notablelabs.com|Uzoq muddatli qarzning o'z kapitaliga nisbati Viracta Therapeutics, Inc. VIRX|MorphoSys Inc (MOR) - Uzoq muddatli majburiyatlarning kapitalga nisbati|NAYA - Uzoq muddatli qarzning o'z kapitaliga nisbati|AAPGV (Ascentage) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi